Michel Goldman

Prof. Michel Goldman

Institute for Interdisciplinary Innovation in healthcare, Université libre de Bruxelles, 1180 Brussels, Belgium
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2020 in Nature Medicine
Verified
Journal Article
Open access
PDF file
MGMarius Gilbert
Marius Gilbert
MDMathias Dewatripont
Mathias Dewatripont
EMEric Muraille
Eric Muraille
JPJean-Philippe Platteau
Jean-Philippe Platteau
Michel GoldmanMichel Goldman
Michel Goldman
In just a few weeks’ time, leaders across the globe will have to start making decisions about lifting lockdown policies, with considerable social, economic and political consequences. We propose a framework for what is arguably the most difficult health challenge that governments have faced since the beginning of this century: a responsible lockdown exit strategy.

25 November 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
SGSerge Goldman
Serge Goldman
DBDominique Bron
Dominique Bron
TTThomas Tousseyn
Thomas Tousseyn
IVIrina Vierasu
Irina Vierasu
LDLaurent Dewispelaere
Laurent Dewispelaere
Michel GoldmanMichel Goldman
Michel Goldman
Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression of lymphomatous lesions after administration of a BNT162b2 mRNA vaccine booster in a man recently diagnosed with AITL.

24 May 2021 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
Michel GoldmanMichel Goldman
Michel Goldman
CHCédric Hermans
Cédric Hermans
Michel Goldman and Cédric Hermans discuss thrombotic mechanisms in COVID-19 and rare adverse reactions to SARS-CoV-2 vaccinations.

1 August 2024 in Journal of Political Economy
Verified
Journal Article
Closed access
Michel GoldmanMichel Goldman
Michel Goldman
JTJean Tirole
Jean Tirole

25 November 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
AFAlain Fischer
Alain Fischer
MDMathias Dewatripont
Mathias Dewatripont
Michel GoldmanMichel Goldman
Michel Goldman

15 January 2020 in Frontiers in Medicine
Verified
Journal Article
Open access
MNMarie Neunez
Marie Neunez
Michel GoldmanMichel Goldman
Michel Goldman
PGPietro Ghezzi
Pietro Ghezzi
Probiotics are over-the-counter products marketed for enhancing human health. Online information has been key in promoting probiotics worldwide. However, only few rigorous clinical studies have met the stringent criteria required to establish the efficacy and safety of probiotics. The present study was undertaken to assess the information quality of webpages referring to probiotics and to compare the recommendations available online with the information collected from trusted scientific sources. We evaluated 150 webpages returned by Google searching “probiotics” in terms of typology of website, health information quality based on the JAMA score and the HONcode certification, as well as completeness of the information based on the presence of four criteria: (1) links to scientific references supporting health claims, (2) cautionary notes about level of evidence for alleged benefits, (3) safety considerations, and (4) regulatory status. We then enumerated the health claims mentioned online and the corresponding clinical trials and reviews registered in the Cochrane library. Finally, the conclusions of Cochrane reviews were used to assess the level of scientific evidence of the information available through Google search. HON-certified websites were significantly more frequent in the top 10 websites than in the remaining websites. In terms of completeness of information, only 10% of webpages met all four criteria, 40% had a cautionary note on benefits, 35% referred to scientific literature, and only 25% mentioned potential side effects. The results of the content analysis led us to conclude that: (1) the most frequent typologies of webpages returned by Google are commercial and news, (2) commercial websites on average provide the least reliable information, and (3) significant numbers of claimed benefits of probiotics are not supported by scientific evidence. This study highlights important biases in the probiotics information available online, underlining the need to improve the quality and objectivity of information provided to the public.